Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
523.32+19.83 (+3.94%)
At close: 04:03PM EDT
523.32 -0.02 (-0.00%)
After hours: 04:12PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/19/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3832.70
52 Week Low 3468.86
50-Day Moving Average 3542.31
200-Day Moving Average 3674.91

Share Statistics

Avg Vol (3 month) 3233.6k
Avg Vol (10 day) 3244.33k
Shares Outstanding 524.84M
Implied Shares Outstanding 6N/A
Float 821.46M
% Held by Insiders 114.31%
% Held by Institutions 174.93%
Shares Short (Apr 28, 2022) 4332.76k
Short Ratio (Apr 28, 2022) 41.37
Short % of Float (Apr 28, 2022) 41.56%
Short % of Shares Outstanding (Apr 28, 2022) 41.11%
Shares Short (prior month Mar 30, 2022) 4319.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 07, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -3.49%
Operating Margin (ttm)20.63%

Management Effectiveness

Return on Assets (ttm)2.64%
Return on Equity (ttm)-0.97%

Income Statement

Revenue (ttm)2.9B
Revenue Per Share (ttm)96.98
Quarterly Revenue Growth (yoy)-3.70%
Gross Profit (ttm)1.67B
EBITDA 730.39M
Net Income Avi to Common (ttm)-101.12M
Diluted EPS (ttm)220.48
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.07B
Total Cash Per Share (mrq)69.25
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)13.78
Current Ratio (mrq)5.09
Book Value Per Share (mrq)512.48

Cash Flow Statement

Operating Cash Flow (ttm)589.23M
Levered Free Cash Flow (ttm)433.23M
Advertisement
Advertisement